CRGX - CARGO Therapeutics, Inc.
4.47
-0.070 -1.566%
Share volume: 10,919,722
Last Updated: 08-18-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$4.54
-0.07
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-12-2024 | 11-12-2024 | 03-12-2025 | 05-08-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 40.806 M | 49.318 M | 47.112 M | 50.134 M | 42.145 M | |
| Selling general and admin | 10.303 M | 11.860 M | 11.180 M | 10.630 M | 11.508 M | |
| Research and development | 30.503 M | 37.458 M | 35.932 M | 39.504 M | 30.637 M | |
| Total expenses | 40.806 M | 49.318 M | 47.112 M | 50.134 M | 88.425 M | |
| 20.86% | -4.47% | 6.41% | 76.38% | |||
| Operating income | -40.806 M | -49.318 M | -47.112 M | -50.134 M | -88.425 M | |
| Ebit | -40.806 M | -49.318 M | -47.112 M | -50.134 M | -88.425 M | |
| Pretax income | -35.801 M | -44.331 M | -41.709 M | -45.466 M | -84.487 M | |
| 23.83% | -5.91% | 9.01% | 85.82% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -35.811 M | -44.348 M | -41.908 M | -45.435 M | -84.498 M | |
| -23.84% | 5.50% | -8.42% | -85.98% |